Press Releases AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:00 12/01/2026 pm IST			5-day change	1st Jan Change
14,120.00 ^GBX	-0.68%		+5.50%	+2.39%

12:58am	Equities Rise Intraday Amid Probe Into Fed Chair Powell	MT
12:25am	Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026	CI

Press Releases

08/01	Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit	BU
22/12	ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer	BU
19/12	Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies	AQ
19/12	AstraZeneca CEO: Europe risks losing production capacity for innovative medicines	AQ
16/12	Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards	AQ
16/12	ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer	BU
16/12	AstraZeneca : Enhertu plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer	PU
12/12	Preserving The Status Quo: Boehringer Ingelheim Awarded Interim Injunction	AQ
04/12	Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides	AQ
04/12	AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH	BU
02/12	Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension	BU
01/12	Cinclus Pharma’s Nomination Committee proposes new representative for the company’s founders to the Board	AQ
26/11	IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers	BU
26/11	AstraZeneca : Imfinzi approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers	PU
24/11	Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology	AQ
24/11	AstraZeneca furthers US manufacturing commitment with $2bn Maryland investment	AQ
22/11	AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalyzing economic growth	BU
20/11	Koselugo (selumetinib) approved in the US	AQ
14/11	AstraZeneca : Director/PDMR Shareholding	PU
10/11	AstraZeneca : Director/PDMR Shareholding	PU
10/11	AstraZeneca : Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial	PU
10/11	Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial	BU
07/11	AstraZeneca seals obesity deal as Pfizer-Novo Nordisk battle for Metsera	AQ
07/11	Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease	BU
06/11	AstraZeneca's 9M and Q3 2025 Financial Results	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Jacobio Strikes New Cancer Drug Deal with AstraZeneca

December 22, 2025 at 05:00 pm IST

AstraZeneca benefits from oncology momentum but valuation limits upside

November 19, 2025 at 06:13 pm IST

AstraZeneca's CEO reportedly considers listing in the United States

July 02, 2025 at 01:09 pm IST